CONTACT NEUROPTIKA

1770 Massachusetts Avenue, Suite 163 Cambridge, MA  02140

United States

Copyright, Neuroptika 2019. All rights reserved.  Terms of site use  |  Privacy Policy

INSIGHTS INTO THE WORLD OF SEEING

Nerve Regenerative Agents for the Treatment of Eye Disorders

 

Preclinical up through Phase 2 dry-eye disease clinical trials have shown that NRO-1 enhanced neurite elongation of Retinal Ganglion Cells (RGCs) significantly.   

NRO-1 PROGRAMS

PRECLINICAL

PHASE 1

PHASE 2

Leber’s Hereditary Optic Neuropathy (LHON)

 
 

BACK TO TOP